Hits and misses in treating diabetic complications: part I Gill Higgins Newsletter Article 05 February 2013 Pages: 3 - 4
Low folate levels linked to increased risk of fatal CHD Newsletter Article 05 February 2013 Pages: 5 - 5
Some progress with hepatitis B vaccination schedules Newsletter Article 05 February 2013 Pages: 5 - 5
Cost effectiveness of immunising varicella-exposed gravida Newsletter Article 05 February 2013 Pages: 7 - 7
Fluoxetine vs tricyclics: similar outcomes, so consider preferences Newsletter Article 05 February 2013 Pages: 7 - 7
Long-awaited clinical data for platelet factors Larry Prescott Newsletter Article 05 February 2013 Pages: 9 - 10
Lithium gamma-linolenate: a new approach to pancreatic cancer Newsletter Article 05 February 2013 Pages: 10 - 10
Fadrozole has similar efficacy to megestrol in breast cancer Newsletter Article 05 February 2013 Pages: 11 - 11
Improved survival with intensive reinduction therapy in ALL Newsletter Article 05 February 2013 Pages: 12 - 12
Nevirapine adds benefits to zidovudine/didanosine in HIV Newsletter Article 05 February 2013 Pages: 12 - 12
How will leukotriene inhibitors affect asthma management? Larry PrescottGill Higgins Newsletter Article 05 February 2013 Pages: 13 - 14
Nadroparin calcium effective alternative for bed-bound patients Newsletter Article 05 February 2013 Pages: 15 - 15
Ceftriaxone and ciprofloxacin: similar efficacy in pneumonia Newsletter Article 05 February 2013 Pages: 15 - 15
Ciprofloxacin for empirical treatment of gastroenteritis? Newsletter Article 05 February 2013 Pages: 17 - 17
Cherry not flavour of the day for paediatric antibacterials Newsletter Article 05 February 2013 Pages: 17 - 17
Pravastatin + squalene effective in elderly with hypercholesterolaemia Newsletter Article 05 February 2013 Pages: 18 - 18
Clonidine may help in ADHD-associated sleep disturbances Newsletter Article 05 February 2013 Pages: 19 - 19
ACE inhibitor-thiazide combinations for Blacks with hypertension Newsletter Article 05 February 2013 Pages: 19 - 19
Ondansetron stable in combination with antineoplastics Newsletter Article 05 February 2013 Pages: 20 - 20
Low-dose, low-risk NSAIDs best for first-line therapy Newsletter Article 05 February 2013 Pages: 21 - 21